Blog Grid

September 15, 2018

PromarkerD in The Australian

Australian test for 30 million diabetics   A new Australian-developed blood test could help 30 million American diabetics predict whether they will develop kidney disease. Using technology developed by a Perth-based firm, doctors in the United States will be able to predict whether diabetes patients will require a kidney transplant or dialysis within four years, […]

DMG News
May 6, 2018

Professor Borody | The Today Show

Professor Borody MD of the CDD appeared on the Today Show to discuss FMT and gut health and to call for extra donors due to an increase in demand for FMT treatments.

DMG News
April 18, 2018

CDD featured in the Sydney Morning Herald and The Age

Morton was referred to Professor Thomas Borody, a gastroenterologist and FMT pioneer, who prescribed anti-inflammatory drugs and – the game changer, according to Morton  – faecal capsules, made bespoke at Borody’s Sydney clinic. Morton, who takes four capsules each day, has been symptom-free since September 2016. “It feels fantastic. It allows me to live a […]

DMG News
July 3, 2017

Press Release | CDD appoints DMG

The world leader in FMT and digestive diseases, the Centre for Digestive Diseases (CDD) has appointed DMG for media relations as part of a rapid growth strategy for the company. Based in Sydney, Australia, the CDD headed by Professor Thomas Borody is the world leader for innovative digestive diseases treatment that cannot be treated using […]

Biopharma, Clinical Trials, Tech
July 3, 2017

Press Release | DMG selected for ZKP ASX listing

DMG investor relations has been selected to provide investor marketing services for leading China tech firm ZKP. DMG services include advanced online investor relations, fact sheets, presentations, and roadshows as well as news media coverage about the listing.

Investor Relations